Find a Clinical Trial

KO-MEN-008 A Study to Investigate the Safety and Tolerability of Ziftomenib Combinations in Patients with Relapsed/Refractory Acute Myeloid Leukemia

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature

Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing with a Left Ventricular Epicardial Lead in Patients with Heart Failure (HF) with Left Ventricular Ejection Fraction (LVEF) ≤

MSK 22-321: A Randomized Phase II Study of Sotorasib versus Continued Consolidation Durvalumab in Patients with KRAS G12C Mutant Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) with Persistent ctDNA Defined

MSK 23-007 Phase II Of VS-6766 In RAF Dimer-Driven RAI-Refractory Differentiated and Anaplastic Thyroid Cancer Patients

Treatment Naïve HIV-1 infected subjects/ A Phase 3 Multicenter, Double-blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK 1439) 100 mg Once Daily Versus

Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

Prospective Observational Study of Respiratory Support Provided to Premature Infants at Risk for Respiratory Distress Syndrome

A Long-Term Follow-up Study to Evaluate the Durability of Virologic Response and/or Viral Resistance Patterns of Subjects with Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a

The Project Every Child Protocol: A Registry, Eligibility, Screening, Biology and Outcome Study

Quorum Novartis Signature study, CBGJ398XUS04: Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 6 – BGJ398 for patients with tumors with FGFR genetic

ARST1321: Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC#737754, IND#118613)

The Effects of Harp Music on Anxiety, Depression, and Nausea in Cancer Patients Receiving Chemotherapy

ACNS1123:  Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors. 

AEWS1221: Randomized Phase II Trial Evaluating the Addition of the IGF-IR Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multi-agent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing

Hepatitis C Registry (GS-US-248-0123): A long term follow-up registry study of subjects who did not achieve sustained virologic response in Gilead-sponsored trials in subjects with chronic hepatitis C infection (2_PRO00000638)

Hepatitis C Study: AI443-102- A Phase 3 Evaluation of a daclatasvir/asunaprevir/BMS-791325 Fixed Dose Combination in Non-cirrhotic Subjects with Genotype 1 Chronic Hepatitis C (2_PRO00001431)

Hepatitis C: A randomized, double-blind, controlled study to evaluate the efficacy and safety of the combination of ABT-450/ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 with and without ribavirin (RBV) in treatment-naïve adults

HIV-1/ A Phase IIIb, randomized, open-label study of the safety and efficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in HIV-1 infected antiretroviral therapy

Multiple Sclerosis: A multicenter, open-label, extension study to evaluate the long-term safety and efficacy of BIIB019, daclizumab high yield process (DAC HYP), monotherapy in subjects with multiple sclerosis who have

Multicenter, Double-Blind Placebo-Controlled, Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease

INDUCTION IN NULLIPAROUS WOMEN AT 39 WEEKS TO PREVENT ADVERSE OUTCOMES: A RANDOMIZED CONTROLLED TRIAL

A031201: Phase III Trial of Enzalutamide (NSC#766085) versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

Lymphocytic Leukemia/ E1912: A Randomized Phase III Study of PCI-32765-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL) (PRO00002012 –

Cardiology/ Medtronic AdaptResponse Study (1_PRO00002070)